Human Mad Cow Brain Disease Appears Within Eleven Days After COVID-19 Vaccine

Want Instant Blog Updates?

Get an email whenever we publish a new article!
PLEASE NOTE:
This subscribe option does not work in some browsers with ad blockers. To ensure your sign up request goes through, use the Google Chrome browser when confirming your subscription from your inbox.

March 23, 2023

From Fabio G. C. Carisio on 5/23/23 in VT Uncensored Alternative Foreign Policy Media:

Late French virologist, Luc Montagnier’s research on killer prions in the toxic Spike protein of Covid-19 while censored during the scientific boycott of information the last few years was published after his passage in February 2022 by “his close collaborators and compatriots Jean-Claude Perez, biomathematician” and “Claire Moret-Chalmin, a neurologist at the same institution, gave the study 2 additional strengths:

  • the number of deaths from this human form of “mad cow” in one year has increased again, confirming the alarm;
  • the research finally revised later and published in the Journal of  Vaccine Theory, Practice, and Research(Dallas, USA) of January 12, 2023 was supplemented by the contribution of American biophysicist Stephanie Seneff who works at the Computer Science and Artificial Intelligence Laboratory of the famous Massachusetts Institute of Technology (MIT) in Cambridge (USA)”.

Results of study:

  • Twenty-six cases “analyzed in the present study, the first symptoms of  Creutzfeldt-Jacob Disease appeared on the average within 11.38 days after the injection of  a COVID-19 “vaccine”.
  • “Twenty deaths occurred only 4.76 months after such an injection and 8 of them died suddenly within 2.5 months.
  • For the 6 patients who did not die before the appearance of our preprint article (February 2022), in a review of their status in August 2022 (see updated Figure 5), it was discovered that 5 of them had died and only one International was still living”. 

Access the full article here

_____________________________________________________________________

We've got a lot to talk about

Read More